HOME >> BIOLOGY >> NEWS
Antioxidants during pregnancy may help prevent birth defects tied to alcohol

CHAPEL HILL -- Pregnant women who abuse alcohol may reduce the risk of birth defects in their babies by taking antioxidants during pregnancy, a University of North Carolina at Chapel Hill study indicates.

The new research found a 36 percent reduction in limb malformations in the offspring of pregnant mice exposed to ethanol and at the same time given a newly developed antioxidant compound called EUK-134.

The study appears on-line Friday (June 18) in FASEB-J, the journal of the Federation of American Societies for Experimental Biology.

"What makes this study unique is that it shows for the first time that giving antioxidants to a pregnant mother at the same time she's exposed to alcohol can diminish the incidence of major malformations," said Dr. Kathleen K. Sulik, professor of cell and developmental biology at UNC's School of Medicine.

Antioxidants protect key cellular components by neutralizing the damaging effects of free radicals, natural byproducts of cell metabolism. Free radicals form when oxygen is metabolized, or burned off, by the body. They travel through cells, disrupting the structure of other molecules, causing cellular damage. Such cell damage is believed to contribute to aging and various health problems. Examples of antioxidants are selenium, vitamin C and E, zinc and superoxide dismutase (or SOD), a zinc- and copper- or manganese-containing enzyme that reacts with superoxide radicals to convert them to less dangerous chemical entities.

Dietary antioxidants have attracted considerable interest in the popular press as potential treatments for cancer, atherosclerosis, chronic inflammatory disease and aging.

Sulik, a member of the university's Bowles Center for Alcohol Studies, said a major focus of her research has been cellular mechanisms involved in birth defect formation, particularly those linked to ethanol exposure, such as fetal alc
'"/>


18-Jun-2004


Page: 1 2 3 4

Related biology news :

1. Supplementing Diet With Fruits And Vegetables, Rather Than Vitamins, Provides Needed "Antioxidants"
2. In New Alzheimers Studies, Lab Tests Show Vitamin E And Other Antioxidants Preventing Brain Cell Death
3. Antioxidants May Reduce Harmful Complications Of Diabetes
4. Free Radicals Implicated In Impaired Lung Function; Damage May Be Mitigated By Certain Antioxidants
5. Anxiety during pregnancy affects child behavior
6. Deserts and rainforests are equally productive during drought
7. Germans must research the history of reproductive medicine during the Nazi era
8. Gene therapy tested to protect bone marrow during chemotherapy
9. Researchers find no link between alcohol consumption during pregnancy and asthma during childhood
10. Chemical reaction in birds provides sense of direction during migratory flights
11. AIDS drug helps to keep HBV at bay during chemotherapy for breast cancer

Post Your Comments:
(Date:2/9/2015)... 9, 2015  Lintec of America recently announced an ... nanotube (CNT) macrostructures, including sheets, yarns and ribbons, developed ... Leveraging the vast industrial resources of the global ... , Lintec of America is forming the Nano-Science and ... , focusing on scaling up the manufacturing and commercialization ...
(Date:2/5/2015)... Conn. , Jan. 26, 2015 NXT-ID, Inc. ... the "Company"), a biometric authentication company focused on the ... new corporate website ( http://www.nxt-id.com/ ) as part of ... smart wallet. The Company launched its new consumer website ... Gino Pereira , CEO of NXT-ID said, "Our new ...
(Date:2/5/2015)... Research and Markets ( http://www.researchandmarkets.com/research/6lngtl/global_biometrics ... "Global Biometrics Market (2014-2020): Market Forecast By Technologies, ... to their offering. , In ... is anticipated to overtake North America ... spending towards IT security, government biometric based projects ...
Breaking Biology News(10 mins):Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3
(Date:3/4/2015)... 4, 2015  BioClinica®, Inc., a leading ... today announced that clinical trial professionals representing ... its annual European User Conference in ... the use of its eClinical technologies to ... include: the Microsoft Office-Smart OnPoint CTMS; Express ...
(Date:3/4/2015)... 2015 Launched by the ... in December 2011, ,SARAH, - the French ... versus sorafenib in advanced hepatocellular carcinoma (HCC) has enrolled ... SARAH, a large French study of patients ... HCC) has completed patient enrolment, exceeding its 400-patient target, ...
(Date:3/3/2015)... TORONTO, March 3, 2015 /PRNewswire/ - Aptose Biosciences Inc. ... therapeutics and molecular diagnostics that target the underlying mechanisms ... and seventh-month period ended December 31, 2014. ... year end from May 31 to December 31. As ... reporting today are for the quarter and the seven ...
(Date:3/3/2015)... 03, 2015 Experts and industry insiders ... one event: the Alltech REBELation exploring innovation, inspiration and ... Now in its 31st year, Alltech’s annual international conference ... and the opportunity to join the REBELation at an ... 11:59 p.m. EST, at which point the standard early ...
Breaking Biology Technology:BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 2Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 4Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 2World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 3World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 4
Cached News: